Shares of EnteroMedics Inc. (NASDAQ: ETRM), a development-stage medical device company engaged in the design and development of devices that use neuroblocking technology to treat obesity, its associated co-morbidities, and other gastrointestinal disorders, are up sharply in trading today.
At last check, ETRM shares were trading 7.65% higher at $3.94 on above average volume of 821,607. The stock gained 12.83% in the last three trading sessions.
EnteroMedics today announced the receipt of $3.6 million from the exercise of 1,653,635 warrants through 2012 to date, The company had issued the warrants in December 2010 and September 2011.
ETRM plans to use the proceeds for general corporate purposes. Mark B. Knudson, Ph. D., President and CEO of EnteroMedics, said that ETRM appreciates the investment from its existing stockholders, which continues to support the company’s ability to achieve its milestones and its ongoing strategy.
Recent Comments